CYTOCHROME P450-NULL MICE
- 1 January 1999
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 31 (2) , 437-447
- https://doi.org/10.1081/dmr-100101929
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lesions of Aryl-hydrocarbon Receptor–deficient MiceVeterinary Pathology, 1997
- Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2Pharmacogenetics, 1996
- Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development.Proceedings of the National Academy of Sciences, 1996
- Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism.Proceedings of the National Academy of Sciences, 1996
- Role of cytochrome P4501A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activityPharmacogenetics, 1995
- Neonatal lethality associated with respiratory distress in mice lacking cytochrome P450 1A2.Proceedings of the National Academy of Sciences, 1995
- Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah ReceptorScience, 1995
- Evolution of the P450 gene superfamily:Trends in Genetics, 1990
- Human cDNA‐Expressed Cytochrome P450 IA2: Mutagen Activation and Substrate SpecificityMolecular Carcinogenesis, 1989
- Tissue-specific expression of the mouse dioxin-inducible P(1)450 and P(3)450 genes: differential transcriptional activation and mRNA stability in liver and extrahepatic tissues.Molecular and Cellular Biology, 1986